MEIP Share Price

Open 1.60 Change Price %
High 1.65 1 Day 0.00 0.00
Low 1.57 1 Week -0.06 -3.66
Close 1.58 1 Month 0.13 8.97
Volume 685232 1 Year -0.11 -6.51
52 Week High 2.28
52 Week Low 0.00
MEIP Important Levels
Resistance 2 1.65
Resistance 1 1.62
Pivot 1.60
Support 1 1.54
Support 2 1.51
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

MEI Pharma, Inc. (NASDAQ: MEIP)

MEIP Technical Analysis 1.5
As on 2nd Dec 2016 MEIP Share Price closed @ 1.58 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.48 & Sell for SHORT-TERM with Stoploss of 1.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
MEIP Target for December
1st Target up-side 1.74
2nd Target up-side 1.87
3rd Target up-side 2.01
1st Target down-side 1.34
2nd Target down-side 1.21
3rd Target down-side 1.07
MEIP Other Details
Segment EQ
Market Capital 24491034.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.meipharma.com
MEIP Address
MEIP
11975 El Camino Real
Suite 101
San Diego, CA 92130
United States
Phone: 858-792-6300
MEIP Latest News
Penny Stock Drawing Interest: Focus On MEI Pharma, Inc. (NASDAQ:MEIP)   Duncan Research   - 02nd Dec 16
Price Target Of MEI Pharma, Inc. (NASDAQ:MEIP) Stock At $2.25   Enterprise Leader   - 01st Dec 16
Checking the Piotroski Score on Shares of MEI Pharma, Inc. (NASDAQ:MEIP)   Wall Street Lion   - 01st Dec 16
Penny Stock News: Putting the Spotlight On MEI Pharma, Inc. (NASDAQ:MEIP)   Duncan Research   - 30th Nov 16
MEI Pharma, Inc. (NASDAQ:MEIP) Insider Trading Report   The Newburgh Press   - 29th Nov 16
MEI Pharma Reports First Quarter Fiscal Year 2017 Results   PR Newswire (press release)   - 09th Nov 16
MEI Pharma Reports Fiscal Year 2016 Results   PR Newswire (press release)   - 06th Sep 16
MEI Pharma shares jump 51% in pre-market trade after $20 mln drug deal   MarketWatch   - 08th Aug 16
MEI Pharma Announces New Clinical Data from First-in-Human Study of ME-401, A ...   PR Newswire (press release)   - 20th Apr 16
MEI Pharma to Present at Needham Healthcare Conference   PR Newswire (press release)   - 05th Apr 16
Interactive Technical Analysis Chart MEI Pharma, Inc. ( MEIP NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on MEI Pharma, Inc.
MEIP Business Profile
MEI Pharma, Inc., formerly Marshall Edwards, Inc., is a development-stage oncology company. The Company is engaged in the development of drugs for the treatment of cancer. The Company focuses on the clinical development of therapeutics targeting cancer metabolism. The Company is a wholly owned subsidiary of Novogen Limited (Novogen). As of September 26, 2011, Novogen owned approximately 51.5% interests in the Company. The Company's has two geographic segments: the United States and Australia. The Company has two clinical product development programs, which include NADH Oxidase Inhibitors and Mitochondrial Inhibitors. NADH Oxidase Inhibitors includes Phenoxodiol and ME-143. Mitochondrial Inhibitors includes NV-128 and ME-344. Marshall Edwards Pty Ltd. is a wholly owned subsidiary of the Company. In February 2013, Novogen Limited completed its exchanged offer through which it was to split off its 63.5% interest in the Company.